Harare, (New Ziana) – The Medicines Control Authority of Zimbabwe (MCAZ) and the Health Professions Authority (HPA) have issued a warning about the unauthorized sale, purchase, and use of Ozempic, a prescription drug often referred to as the “skinny jab.”
Originally developed for managing type 2 diabetes, Ozempic is increasingly being misused for weight loss, raising significant health risks.
In a joint announcement, MCAZ Director-General Richard Rukwata highlighted a notable rise in the illegal distribution of Ozempic through unapproved channels and expressed concern over the public’s misuse of the drug for weight management.
“Recent findings show a growing trend of Ozempic being used for weight loss without medical oversight. Such practices can be hazardous and may result in severe health issues,” said Rukwata.
He said as a prescription medication, Ozempic should only be obtained with a valid prescription and under the close supervision of a certified healthcare provider adding that using the drug for weight loss without professional guidance can lead to serious and potentially fatal consequences.
The authorities advise against acquiring Ozempic from unauthorized sources, including online platforms, social media, unlicensed vendors, or unregistered individuals.
These sources, said Rukwata often lack proper quality control, leading to the distribution of substandard or counterfeit drugs.
Additionally, those involved in the illegal trade of Ozempic have been warned that such actions are criminal offenses that can result in imprisonment.
“Selling medicines without proper licensing from unapproved locations violates Sections 50 and 52 of the Medicines and Allied Substances Control (General) Regulations, 1991, as well as Section 106 of the same regulations. The sale of unregistered medications also contravenes Section 29(1)(a) of the Medicines and Allied Substances Control Act,” said Rukwata.
The Health Professions Act (Chapter 27:19) Section 126 further prohibits unqualified individuals from engaging in acts related to registered professions, meaning that diagnosis and prescribing should only be performed by licensed professionals.
Both the MCAZ and HPA encourage the public to seek medical advice and treatment exclusively from registered health professionals.
“To protect public health, the HPA and MCAZ urge individuals to consult only licensed health practitioners and accredited institutions. Verification can be done through the possession of valid practicing certificates and licenses from the relevant councils,” said the statement.
